Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Cancer Research UK (CRUK) Therapeutic Catalyst

Application deadline

Applications are reviewed three times per year.

Next EOI deadline: 25 September 2026.

Award volume and duration

up to £350,000, up to 24 months

About the call

Provides funding and translational support to accelerate the development of novel cancer therapeutics based on small molecule and antibody-based approaches for adult cancers. Projects are delivered in collaboration with Cancer Research Horizons and are aimed at progressing promising discoveries towards therapeutic development.

The scheme now consists of two award streams:

Target Award

Up to £250,000 for 12-18 months

Supports:

  • identification of novel cancer targets;
  • validation of cancer targets and target dependency;
  • generation of evidence to support clinical positioning and future therapeutic development.

Early Therapy Award

Up to £350,000 for 18-24 months

Supports:

  • hit-identification-enabling activities;
  • assessment of target druggability;
  • progression and optimisation of early therapeutic projects;
  • advancement of novel small molecule and antibody-based therapeutic approaches.

How to apply

For more info on Expression of Interest (EOI), contact: Claire Heride therapeutic.catalyst@cancer.org.uk

Visit the CRUK website to apply

In this section